THE BUSINESS OF HEALTHCARE
M&A insights to keep you one step ahead of the ever-evolving healthcare industry.
March 2021
Behavioral Health
Commanding a Premium Sale Price: Five Areas Where an Owner Can Take Action Now
by Steve Zacharias, Managing Partner for Transact Capital
We often get asked by owners about what they can do now to maximize the future sale value of their business. Here are five general areas where an owner can create exceptional value outside of the more traditional ways of doing so.
Forecasting Healthcare Regulatory Developments in a Biden Administration by Wilson Sonsini et al. for JD Supra
Insights and forecasts on how the Biden administration will impact the healthcare industry in the coming years. Covered topics include Medicare-for-all, drug price negotiations, anti-kickback statutes, telehealth, and more.
What 'Record Deal Flow' Will Mean for Valuations in Various Behavioral Subsectors by Bailey Bryant for Behavioral Health Business
Less mature behavioral health subsectors like outpatient mental health and autism treatment are seeing higher valuations due to its rapid growth, and investors placing an emphasis on forward-looking projections over past performance.
The money behind mental health: How the pandemic increased innovation, investment in behavioral health care by Tina Reid for Fierce Healthcare
The behavioral health space is attracting significant interest from investors and the larger healthcare community. Driving this interest is the decreasing stigma associated with mental healthcare, an increase in evidence-based treatment, shifting regulations for virtual care, and an increased mental health focus by employers.
Alcohol and Drug Treatment Centers Draw Private Equity Backing by Phil Albinus for Middle Market Growth
The COVID lockdowns underscored the scale of the addiction crisis in the United States. The CDC reported 81,000 drug overdose deaths in the 12 months ending May 2020, the record for a 12 month period. This has created a demand for addiction treatment services and interest from financial and strategic buyers.
Top 10 M&A Mistakes Series:
Transact Capital Managing Director, Jonathan Brabrand, authored and released $100 Million Exit: Your Roadmap to the Ultimate Payday in April 2020. The book analyzes large M&A successes and failures to draw practical, actionable advice that company owners can implement to increase the value of their business and be better prepared for an exit. The following is the fourth in a running newsletter series Top 10 M&A Mistakes detailing passages from Jonathan's book.
M&A Mistake #7: Over-Emphasis on Price
Ask any business owner what the primary goal of a sale process is, and chances are their top answer will be to maximize purchase price. And that’s understandable; a big payday is clearly one of the
top reasons owners sell their business. But price is not the only factor you should consider when evaluating exit alternatives. In fact, I have seen several transactions where top dollar did not win the day. Savvy sellers recognize there is more to maximize in an exit transaction than purchase price alone.
Who is Transact Capital?
Transact Capital Partners is a full-service mergers and acquisitions advisory and investment banking firm headquartered in Richmond VA with offices in Roanoke VA, Chicago IL, Orlando FL, and Lexington KY. The firm's strong network of relationships with private investors, senior lenders, private equity firms and professional advisors offers a significant advantage in representing business owners for the sale of their business. Transact Capital's experienced and motivated team of 17 professionals are dedicated to helping business owners identify and achieve their vision for the potential future of the company.

Securities and investment banking transactions are offered through its 100% owned affiliate Transact Capital Securities, LLC, Member FINRA and SIPC.
To learn more about the Healthcare Advisory Group, please contact Mike Gaetano at (804) 612-7101 or [email protected]